 |
인쇄하기
취소
|
Ahngook signs drug deal with Takeda Korea
Published: 2012-08-30 06:57:00
Updated: 2012-08-30 06:57:00
Ahngook Pharmaceutical said Tuesday it has signed an agreement with Takeda Korea in a move to exclusively distribute the latter’s Zycomb nasal spray solution here.
Zycomb is a combination medicinal product consisting of two different substances (ipratropium bromide + xylometazoline hydrochloride). The drug is used for the treatment of nasal congestion with running nose.
Auh Jin, President...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.